Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Kidney Transplantation 1

Interventions

cryoprecipitate coagulum 1 Tacrolimus 1 Specimen Handling 1 Sirolimus 1 Nivolumab 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 CTLA-4 Antigen 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pseudomyxoma Peritonei × Alemtuzumab × 90 days × Clear all

NCT06084780 2026-04-09

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡